tiprankstipranks
Are Investors Vastly Underestimating CRISPR Therapeutics Stock (NASDAQ:CRSP)?
PremiumMarket NewsAre Investors Vastly Underestimating CRISPR Therapeutics Stock (NASDAQ:CRSP)?
23d ago
Is Beam Therapeutics (NASDAQ:BEAM) Too Late to the Game?
PremiumStock Analysis & Ideas
Is Beam Therapeutics (NASDAQ:BEAM) Too Late to the Game?
24d ago
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
PremiumThe Fly
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
1M ago
Crispr Therapeutics call volume above normal and directionally bullish
PremiumThe FlyCrispr Therapeutics call volume above normal and directionally bullish
2M ago
Crispr Therapeutics price target raised to $66 from $57 at RBC Capital
PremiumThe Fly
Crispr Therapeutics price target raised to $66 from $57 at RBC Capital
2M ago
Crispr Therapeutics price target raised to $70 from $55 at Wells Fargo
PremiumThe Fly
Crispr Therapeutics price target raised to $70 from $55 at Wells Fargo
2M ago
Crispr Therapeutics options imply 7.2% move in share price post-earnings
PremiumThe FlyCrispr Therapeutics options imply 7.2% move in share price post-earnings
2M ago
CRISPR Therapeutics to Present at the Citi 2024 Virtual Oncology Leadership Summit
PremiumPress Releases
CRISPR Therapeutics to Present at the Citi 2024 Virtual Oncology Leadership Summit
2M ago
Crispr Therapeutics initiated with a Peer Perform at Wolfe Research
PremiumThe Fly
Crispr Therapeutics initiated with a Peer Perform at Wolfe Research
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100